Aastrom is a publicly traded biotech company developing stem cell treatment therapies. The CEO is Timothy Mayleben, who replaced George W. Dunbar, who joined in 2006 replacing R. Douglas Armstrong in that role.
It is located at 24 Frank Lloyd Wright Drive, Ann Arbor, MI, at Domino's Farms.
NASDAQ: ASTM - news on Google Finance.
In the news
ANN ARBOR, Mich., March 18, 2010 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM) today reported that its ticker symbol will revert back to ASTM as of March 18, 2010. As a result of the company's reverse stock split which became effective as of February 18, 2010, the company's common stock had been trading on a post-split basis under the temporary trading symbol "ASTMD" for approximately 20 trading days.
- http://www.crainsdetroit.com/article/20091210/EMAIL01/312109995
- 1Q losses are smaller at Aastrom Biosciences, Crain's Detroit Business, November 2008
- George W. Dunbar Joins Aastrom Biosciences as Chief Executive Officer, Aastrom press release, July 2006.
